Hypothesis on Functional Inadequacy of Thioredoxin and Related Systems in Preeclampsia

References

• Chen H L, Yang Y, Hu X-L, Yelavarthi K K, Fishback L L, Hunt J S. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991; 139: 327–35
   PubMed Web of Science ®Google Scholar
• Witkin S S, Liu H-C, Davis O K, Rosenvaks Z. Tumor necrosis factor is present in maternal sera and embryo culture fluids during in vitro fertilization. J Reprod Immunol 1991; 19: 85–93
   PubMed Web of Science ®Google Scholar
• Hill J A. Cytokines considered critical in pregnancy. Am J Reprod Immunol 1992; 28: 123–6
   PubMed Web of Science ®Google Scholar
• Schroecksnadel H, Herold M, Steckel-Berger G, Fuchs D, Wachter H, Dapunt O. Zellvermittelte Immunitaet bei schwangerschaftsinduzierten Hochdruckerkrank-ungen. Geburtsh Frauenheilk 1992; 52: 592–5
   PubMed Web of Science ®Google Scholar
• Kupferminc M J, Peaceman A M, Wigton T R, Rehnberg K A, Socol M. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170: 1752–9
   PubMed Web of Science ®Google Scholar
• Vince G, Starkey P M, Austgulen R, Kwiatkowski D, Redman C WG. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20–5
   PubMedGoogle Scholar
• Keith J C, Rowles T K, Dilorenzo K, Mishra S, Misra H P. J Perinatol 1993; 13: 417–8
   PubMedGoogle Scholar
• Visser W, Beckmann I, Bremer H A, Lim H L, Wallenburg H CS. Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 1994; 101: 1081–2
   PubMedGoogle Scholar
• Keith J C, Pijnenborg R, Spitz B, Hanssens M, van Assche F A. Assessment of differential serum cytotoxicity in gestational hypertension using a fibrosarcoma cell line and the MTT assay. Hypertens Pregnancy 1994; 14: 81–90
   Web of Science ®Google Scholar
• Greer I A, Lyall F, Perera T, Boswell F, Macara M. Increased concentrations of cytokines IL6 and IL1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction. Obstetrics Gynecol 1994; 84: 937–40
   PubMed Web of Science ®Google Scholar
• Schiff E, Friedman S A, Baumann P, Sibai B M, Romero R. Tumor necrosis factor-alpha in pregnancies associated with preeclampsia or small for gestational-age newborns. Am J Obstet Gynecol 1994; 170: 1224–9
   PubMed Web of Science ®Google Scholar
• Meekins J W, Mc Laughlin P J, West D C, Mc Fadyen I R, Johnson P M. Endothelial cell activation by tumour necrosis factor-alpha and the development of pre-eclampsia. Clin Exp Immunol 1994; 98: 110–4
   PubMed Web of Science ®Google Scholar
• Stark M, Jones S J, Johansen K, Blake L, Shaw R. Tumour necrosis factor. Lancet 1995; 345
   Google Scholar
• Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLauchlin M K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–4
   PubMed Web of Science ®Google Scholar
• Roberts J M, Redman C WG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447–51
   PubMed Web of Science ®Google Scholar
• Stark JM. Pre-eclampsia and cytokine-induced oxidative stress. Br J Obstet Gynaecol 1993; 100: 105
   PubMedGoogle Scholar
• Schulze-Osthoff K, Bakker A C, Vanhaesebroeck B, Beyaert R, Jacob W A, Fiers W. Cytotoxic activity of tumour necrosis factor is mediated by early damage of mitochondrial functions: evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992; 267: 5317–23
   PubMed Web of Science ®Google Scholar
• Feingold K R, Serio M K, Adi S, Moser A H, Grunfeld C. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 1989; 124: 2336–42
   PubMed Web of Science ®Google Scholar
• Gamble J R, Smith W B, Vadas M A. TNF modulation of endothelial and neutrophil adhesion. The Molecules and Their Emerging Role in Medicine Tumor Necrosis Factors, B Beutler. Raven Press, New York 1992; 65
   Google Scholar
• Clauss M, Ryan J, Stern D. Modulation of endothelial cell hemostatic properties by TNF: insights into the role of endothelium in the host response to inflammatory stimuli. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, B Beutler. Raven Press, New York 1992; 49
   Google Scholar
• van der Poll T, van Deventer S J, Pasterkamp G, van Mourik J A, Buller H R, ten Cate J W. Tumor necrosis factor induces von Willebrand factor release in healthy humans. Thromb Haemostasis 1992; 67: 623–6
   PubMed Web of Science ®Google Scholar
• Austgulen R, Lien E, Liabbakk N-B, Jacobsen G, Arntzen K J. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obst Gynecol Reprod Biol 1994; 57: 149–55
   PubMed Web of Science ®Google Scholar
• Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989; 284: 13963–6
   Google Scholar
• Mitchell M D, Lundin-Schuller S, Edwin S S. Endothelin production by amnion and its regulation by cytokines. Am J Obstet Gynecol 1991; 165: 120–4
   PubMed Web of Science ®Google Scholar
• Lamas S, Michel T, Brenner B M, Marsden P A. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha. Am J Physiol 1991; 261: C634
   Web of Science ®Google Scholar
• Lyall F, Young A, Greer I. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995; 173: 714–8
   PubMed Web of Science ®Google Scholar
• Sambucetti L C, Cherrington J M, Wilkinson G WG, Mocarski E S. NF-kB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J 1989; 8: 3251–8
   Web of Science ®Google Scholar
• Faller Andrews N C. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991; 19: 2499
   PubMed Web of Science ®Google Scholar
• Schreck R, Rieber P, Baeuerle P A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J 1991; 10: 2247–58
   PubMed Web of Science ®Google Scholar
• Israel N, Gougerot-Pocidalo M-A, Aillet F, Virelizier J-L. Redox status of cells influences constitutive or induced NF-kB translocation and HIV long terminal repeat activity in human T and monocyte cell lines. J Immunol 1992; 149: 3386–93
   PubMed Web of Science ®Google Scholar
• Zabel U, Baeuerle P. Purified human IkB can rapidly dissociate the complex of the NF-kB transcription factor with its cognate DNA. Cell 1990; 61: 255–65
   PubMed Web of Science ®Google Scholar
• Zabel U, Schreck R, Baeuerle P A. DNA binding of purified transcription factor NF-kB. J Biol Chem 1991; 266: 252–60
   PubMed Web of Science ®Google Scholar
• Orozco C, Clark I Q, Cock I E, Clarke F M. A description of the basic system of components in pregnant mice sera responsible for “early pregnancy factor” activity. J Reprod Fertil 1994; 100: 291–7
   PubMedGoogle Scholar
• Morton H, Rolfe B, Clunie G JA. An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet 1979; 1: 394–7
   Web of Science ®Google Scholar
• Natsuyama S, Noda Y, Yamashita M, Nagahama Y, Mori T. Superoxide dismutase and thioredoxin restore defective p34cdc2 kinase activation in mouse two-cell block. Biochim Biophys Acta 1993; 1176: 90–4
   PubMed Web of Science ®Google Scholar
• Kobayashi F, Sagawa N, Nanbu Y, Kitaoka Y, Mori T, Fujii S, Nakamura H, Masutani H, Yodoi I. Biochemical and topological analysis of adult T-cell leukemia-derived factor, homologous to thioredoxin, in the human uterus. Human Reproduction 1995; 10: 1603–8
   PubMed Web of Science ®Google Scholar
• Perkins A V, DiTrapani G, Mc Kay M S, Clarke F M, Clarke F M. Immunochemical localization of thioredoxin in human trophoblast and decidua. Placenta 1995; 16: 635–42
   PubMed Web of Science ®Google Scholar
• Grippo J F, Holmgren A, Pratt W B. Proof that the endogenous, heat-stable glucocorticoid receptor activating factor is thioredoxin. J Biol Chem 1985; 260: 93–7
   PubMed Web of Science ®Google Scholar
• Spector A, Yan G-Z, Huang R-RC, Mc Dermott M J, Gascoyne P RC, Pigiet V. The effect of H 2O2 upon thioredoxin-enriched lens epithelial cells. J Biol Chem 1985; 263: 4984
   Google Scholar
• Fernando M R, Nanri H, Yoshitake S, Nagata-Kuno K, Minakami S. Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells. Eur J Bio-chem 1992; 209: 917–22
   Google Scholar
• Matthews J R, Wakasugi N, Virelizier J-L, Yodoi J, Hay R T. Thioredoxin regulates the DNA binding activity of NF-kB by reduction of a disulphide bond involving cysteine 62. Nucl Acids Res 1992; 20: 3821–30
   PubMed Web of Science ®Google Scholar
• Schenk H, Vogt M, Droege W, Schulze-Osthoff K. Thioredoxin as a potent costimulus of cytokine activity. J Immunol 1996; 156: 765–71
   PubMed Web of Science ®Google Scholar
• Schenk H, Klein M, Erdbrugger W, Droge W, Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci USA 1994; 91: 1672–6
   PubMed Web of Science ®Google Scholar
• Matsuda M, Masutani H, Nakamura H, Miyajima S, Yamuchi A, Yonehara S, Uchida A, Irijami K, Horiuchi A, Yodoi J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol 1991; 147: 3837–41
   PubMed Web of Science ®Google Scholar
• Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, Tursz T. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA 1990; 87: 8282–6
   PubMed Web of Science ®Google Scholar
• Bjornstedt M, Xue X, Huang W, Akesson B, Holmgren A. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem 1994; 269: 29382–4
   PubMed Web of Science ®Google Scholar
• Sugioka K, Shimosegawa Y, Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 1987; 210: 37–9
   PubMed Web of Science ®Google Scholar
• Nakano M, Sugioka K, Naito I, Takekoshi S, Niki E. Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hy-droxy estradiol. Biochem Biophys Res Commun 1987; 142: 919–24
   PubMed Web of Science ®Google Scholar
• Mazière C, Auclair M, Ronveaux M-F, Salmon S, Santus R, Mazière J-C. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 1991; 89: 175–82
   PubMed Web of Science ®Google Scholar
• Maruyama T, Sachi Y, Furuke K, Kitaoka Y, Tanaguiueda Y, Nakajima S, Nakanoin K, Yodoi J. Hormonal regulation of human thioredoxin adult T-cell leukaemia derived factor (HTRX/ADF) expression in human endometrium in vivo and in vitro [abstract]. Biol Reprod 1995; 52: Sl
   Web of Science ®Google Scholar
• Carbarns N JB, Neale M L, Stark J M. Protective effect of an oestrogen against endotoxin-induced liver enzyme release. Int J Exp Path 1993; 74: 309–14
   PubMed Web of Science ®Google Scholar
• Danenberg H G, Albert G, Lustig S, Ben-Nathan D. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Anti-microb Agents Chemother 1992; 36: 2275
   PubMed Web of Science ®Google Scholar
• Long P A, Abell D A, Beischer N A. Fetal growth and placental function assessed by urinary estriol excretion before the onset of preeclampsia. Am J Obstet Gynecol 1979; 135: 344–7
   PubMed Web of Science ®Google Scholar
• Gant N F, Hutchinson H T, Siiteri P K, Macdonald P C. Study of the metabolic clearance rate of dehydroepiandrosterone sulfate in pregnancy. Am J Obstet Gynecol 1971; 111: 555–61
   PubMed Web of Science ®Google Scholar
• Chesley L C. Hypertensive Disorders of Pregnancy. Appleton-Century-Crofts, New York 1978; 455
   Google Scholar
• Fuchs F, Klopper A. Endocrinology of Pregnancy, 3rd ed. Harper and Row, Philadelphia 1983; 123
   Google Scholar
• Laverty C RA, Fortune D W, Beischer N A. Congenital idiopathic adrenal hypoplasia. Obstetrics Gynecol 1973; 41: 655–64
   PubMed Web of Science ®Google Scholar
• Harbour-Mc Menamin D, Smith E M, Blalock J E. Production of immunoreactive chorionic gonadotropin during mixed lymphocyte reactions: a possible selective mechanism for genetic diversity. Proc Natl Acad Sci USA 1986; 83: 6834–8
   PubMed Web of Science ®Google Scholar
• Dekker G A, de Vries J IP, Doelitzsch P M, Huijgens P C, von Blomberg B ME, Jakobs C, van Geijn H. Underlying disorders associated with severe early onset preeclampsia. Am J Obstet Gynecol 1995; 175: 1042–5
   Google Scholar
• Cha M K, Kim I-H. Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell. Biochim Biophys Res Commun 1995; 217: 900–7
   PubMed Web of Science ®Google Scholar
• Jia L, Bonaventura C, Bonaventura J, Stamler J S. S-Nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221–6
   PubMed Web of Science ®Google Scholar